Neglected Tropical Disease Treatment Market (2025 - 2033) Size, Share & Trends Analysis Report By Disease (Dengue, Rabies, Trachoma, Chagas Disease), By Product (Drugs, Vaccines), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Disease
                        1.2.2. Product
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
                        3.3.4. Patent Expiry Analysis
                        3.3.5. Pricing Analysis
Chapter 4. Neglected Tropical Disease Treatment Market: Disease Business Analysis
                    4.1. Disease Market Share, 2024 & 2033
                    4.2. Disease Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
                    4.4. Dengue
                        4.4.1. Dengue Market, 2021 - 2033 (USD Million)
                    4.5. Rabies
                        4.5.1. Rabies Market, 2021 - 2033 (USD Million)
                    4.6. Trachoma
                        4.6.1. Trachoma Market, 2021 - 2033 (USD Million)
                    4.7. Buruli Ulcer
                        4.7.1. Buruli Ulcer Market, 2021 - 2033 (USD Million)
                    4.8. Yaws
                        4.8.1. Yaws Market, 2021 - 2033 (USD Million)
                    4.9. Leprosy
                        4.9.1. Leprosy Market, 2021 - 2033 (USD Million)
                    4.10. Chagas Disease
                        4.10.1. Chagas Disease Market, 2021 - 2033 (USD Million)
                    4.11. Human African Trypanosomiasis (Sleeping Sickness)
                        4.11.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2021 - 2033 (USD Million)
                    4.12. Leishmaniases
                        4.12.1. Leishmaniases Market, 2021 - 2033 (USD Million)
                    4.13. Soil-transmitted Helminthiases
                        4.13.1. Soil-transmitted Helminthiases Market, 2021 - 2033 (USD Million)
                    4.14. Others
                        4.14.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Neglected Tropical Disease Treatment Market: Product Business Analysis
                    5.1. Product Market Share, 2024 & 2033
                    5.2. Product Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
                    5.4. Drugs
                        5.4.1. Drugs Market, 2021 - 2033 (USD Million)
                        5.4.2. Anti-Parasite
                            5.4.2.1. Anti-Parasite Market, 2021 - 2033 (USD Million)
                        5.4.3. Antifungal
                            5.4.3.1. Antifungal Market, 2021 - 2033 (USD Million)
                        5.4.4. Antibiotics
                            5.4.4.1. Antibiotics Market, 2021 - 2033 (USD Million)
                        5.4.5. Others
                            5.4.5.1. Others Market, 2021 - 2033 (USD Million)
                    5.5. Vaccines
                        5.5.1. Vaccines Market, 2021 - 2033 (USD Million)
Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2024 & 2033
                    6.2. Regional Market Dashboard
                    6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    6.4. North America
                        6.4.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
                        6.4.2. U.S.
                            6.4.2.1. Key Country Dynamics
                            6.4.2.2. Target Disease Prevalence
                            6.4.2.3. Regulatory Framework
                            6.4.2.4. Reimbursement Framework
                            6.4.2.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.3. Canada
                            6.4.3.1. Key Country Dynamics
                            6.4.3.2. Target Disease Prevalence
                            6.4.3.3. Regulatory Framework
                            6.4.3.4. Reimbursement Framework
                            6.4.3.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.4. Mexico
                            6.4.4.1. Key Country Dynamics
                            6.4.4.2. Target Disease Prevalence
                            6.4.4.3. Regulatory Framework
                            6.4.4.4. Reimbursement Framework
                            6.4.4.5. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Europe
                        6.5.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.2. UK
                            6.5.2.1. Key Country Dynamics
                            6.5.2.2. Target Disease Prevalence
                            6.5.2.3. Regulatory Framework
                            6.5.2.4. Reimbursement Framework
                            6.5.2.5. Uk Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.3. Germany
                            6.5.3.1. Key Country Dynamics
                            6.5.3.2. Target Disease Prevalence
                            6.5.3.3. Regulatory Framework
                            6.5.3.4. Reimbursement Framework
                            6.5.3.5. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.4. France
                            6.5.4.1. Key Country Dynamics
                            6.5.4.2. Target Disease Prevalence
                            6.5.4.3. Regulatory Framework
                            6.5.4.4. Reimbursement Framework
                            6.5.4.5. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.5. Italy
                            6.5.5.1. Key Country Dynamics
                            6.5.5.2. Target Disease Prevalence
                            6.5.5.3. Regulatory Framework
                            6.5.5.4. Reimbursement Framework
                            6.5.5.5. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.6. Spain
                            6.5.6.1. Key Country Dynamics
                            6.5.6.2. Target Disease Prevalence
                            6.5.6.3. Regulatory Framework
                            6.5.6.4. Reimbursement Framework
                            6.5.6.5. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.7. Denmark
                            6.5.7.1. Key Country Dynamics
                            6.5.7.2. Target Disease Prevalence
                            6.5.7.3. Regulatory Framework
                            6.5.7.4. Reimbursement Framework
                            6.5.7.5. Denmark Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.8. Sweden
                            6.5.8.1. Key Country Dynamics
                            6.5.8.2. Target Disease Prevalence
                            6.5.8.3. Regulatory Framework
                            6.5.8.4. Reimbursement Framework
                            6.5.8.5. Sweden Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.9. Norway
                            6.5.9.1. Key Country Dynamics
                            6.5.9.2. Target Disease Prevalence
                            6.5.9.3. Regulatory Framework
                            6.5.9.4. Reimbursement Framework
                            6.5.9.5. Norway Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.6. Asia Pacific
                        6.6.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.2. Japan
                            6.6.2.1. Key Country Dynamics
                            6.6.2.2. Target Disease Prevalence
                            6.6.2.3. Regulatory Framework
                            6.6.2.4. Reimbursement Framework
                            6.6.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.3. China
                            6.6.3.1. Key Country Dynamics
                            6.6.3.2. Target Disease Prevalence
                            6.6.3.3. Regulatory Framework
                            6.6.3.4. Reimbursement Framework
                            6.6.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.4. India
                            6.6.4.1. Key Country Dynamics
                            6.6.4.2. Target Disease Prevalence
                            6.6.4.3. Regulatory Framework
                            6.6.4.4. Reimbursement Framework
                            6.6.4.5. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.5. Australia
                            6.6.5.1. Key Country Dynamics
                            6.6.5.2. Target Disease Prevalence
                            6.6.5.3. Regulatory Framework
                            6.6.5.4. Reimbursement Framework
                            6.6.5.5. Australia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.6. South Korea
                            6.6.6.1. Key Country Dynamics
                            6.6.6.2. Target Disease Prevalence
                            6.6.6.3. Regulatory Framework
                            6.6.6.4. Reimbursement Framework
                            6.6.6.5. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.7. Thailand
                            6.6.7.1. Key Country Dynamics
                            6.6.7.2. Target Disease Prevalence
                            6.6.7.3. Regulatory Framework
                            6.6.7.4. Reimbursement Framework
                            6.6.7.5. Thailand Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.7. Latin America
                        6.7.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.7.2. Brazil
                            6.7.2.1. Key Country Dynamics
                            6.7.2.2. Target Disease Prevalence
                            6.7.2.3. Regulatory Framework
                            6.7.2.4. Reimbursement Framework
                            6.7.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.7.3. Argentina
                            6.7.3.1. Key Country Dynamics
                            6.7.3.2. Target Disease Prevalence
                            6.7.3.3. Regulatory Framework
                            6.7.3.4. Reimbursement Framework
                            6.7.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.8. Middle East and Africa
                        6.8.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.2. South Africa
                            6.8.2.1. Key Country Dynamics
                            6.8.2.2. Target Disease Prevalence
                            6.8.2.3. Regulatory Framework
                            6.8.2.4. Reimbursement Framework
                            6.8.2.5. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.3. Saudi Arabia
                            6.8.3.1. Key Country Dynamics
                            6.8.3.2. Target Disease Prevalence
                            6.8.3.3. Regulatory Framework
                            6.8.3.4. Reimbursement Framework
                            6.8.3.5. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.4. UAE
                            6.8.4.1. Key Country Dynamics
                            6.8.4.2. Target Disease Prevalence
                            6.8.4.3. Regulatory Framework
                            6.8.4.4. Reimbursement Framework
                            6.8.4.5. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.5. Kuwait
                            6.8.5.1. Key Country Dynamics
                            6.8.5.2. Target Disease Prevalence
                            6.8.5.3. Regulatory Framework
                            6.8.5.4. Reimbursement Framework
                            6.8.5.5. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Participant Overview
                    7.2. Company Market Position Analysis
                    7.3. Company Categorization
                    7.4. Strategy Mapping
                    7.5. Company Profiles/Listing
                        7.5.1. F. Hoffmann-La Roche Ltd
                            7.5.1.1. Overview
                            7.5.1.2. Financial Performance
                            7.5.1.3. Disease Benchmarking
                            7.5.1.4. Strategic Initiatives
                        7.5.2. Bayer AG
                            7.5.2.1. Overview
                            7.5.2.2. Financial Performance
                            7.5.2.3. Disease Benchmarking
                            7.5.2.4. Strategic Initiatives
                        7.5.3. GlaxoSmithKline plc
                            7.5.3.1. Overview
                            7.5.3.2. Financial Performance
                            7.5.3.3. Disease Benchmarking
                            7.5.3.4. Strategic Initiatives
                        7.5.4. Novartis AG
                            7.5.4.1. Overview
                            7.5.4.2. Financial Performance
                            7.5.4.3. Disease Benchmarking
                            7.5.4.4. Strategic Initiatives
                        7.5.5. Pfizer, Inc.
                            7.5.5.1. Overview
                            7.5.5.2. Financial Performance
                            7.5.5.3. Disease Benchmarking
                            7.5.5.4. Strategic Initiatives
                        7.5.6. Eisai Co. Ltd.
                            7.5.6.1. Overview
                            7.5.6.2. Financial Performance
                            7.5.6.3. Disease Benchmarking
                            7.5.6.4. Strategic Initiatives
                        7.5.7. Sanofi
                            7.5.7.1. Overview
                            7.5.7.2. Financial Performance
                            7.5.7.3. Disease Benchmarking
                            7.5.7.4. Strategic Initiatives
                        7.5.8. Astellas Pharma
                            7.5.8.1. Overview
                            7.5.8.2. Financial Performance
                            7.5.8.3. Disease Benchmarking
                            7.5.8.4. Strategic Initiatives
                        7.5.9. Takeda Pharmaceutical Company Limited
                            7.5.9.1. Overview
                            7.5.9.2. Financial Performance
                            7.5.9.3. Disease Benchmarking
                            7.5.9.4. Strategic Initiatives
                        7.5.10. Gilead Sciences.
                            7.5.10.1. Overview
                            7.5.10.2. Financial Performance
                            7.5.10.3. Disease Benchmarking
                            7.5.10.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global neglected tropical disease treatment market, by region, 2021 - 2033 (USD Million)
Table 4. Global neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 5. Global neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 6. North America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
Table 7. North America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 8. North America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 9. U.S. neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 10. U.S. neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 11. Canada neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 12. Canada neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 13. Mexico neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 14. Mexico neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 15. Europe neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
Table 16. Europe neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 17. Europe neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 18. UK neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 19. UK neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 20. Germany neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 21. Germany neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 22. France neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 23. France neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 24. Italy neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 25. Italy neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 26. Spain neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 27. Spain neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 28. Norway neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 29. Norway neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 30. Denmark neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 31. Denmark neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 32. Sweden neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 33. Sweden neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 34. Asia Pacific neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
Table 35. Asia Pacific neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 36. Asia Pacific neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 37. Japan neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 38. Japan neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 39. China neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 40. China neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 41. India neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 42. India neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 43. Australia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 44. Australia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 45. South Korea neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 46. South Korea neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 47. Thailand neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 48. Thailand neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 49. Latin America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
Table 50. Latin America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 51. Latin America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 52. Brazil neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 53. Brazil neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 54. Argentina neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 55. Argentina neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 56. Middle East & Africa Neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
Table 57. Middle East & Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 58. Middle East & Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 59. South Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 60. South Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 61. Saudi Arabia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 62. Saudi Arabia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 63. UAE neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 64. UAE neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
Table 65. Kuwait neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
Table 66. Kuwait neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Neglected tropical disease treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and disease outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Neglected tropical disease treatment market dynamics
Fig. 12 Neglected tropical disease treatment market: Porter’s five forces analysis
Fig. 13 Neglected tropical disease treatment market: PESTLE analysis
Fig. 14 Dengue market, 2021 - 2033 (USD Million)
Fig. 15 Rabies market, 2021 - 2033 (USD Million)
Fig. 16 Trachoma market, 2021 - 2033 (USD Million)
Fig. 17 Buruli ulcer market, 2021 - 2033 (USD Million)
Fig. 18 Yaws market, 2021 - 2033 (USD Million)
Fig. 19 Leprosy market, 2021 - 2033 (USD Million)
Fig. 20 Human african trypanosomiasis (sleeping sickness) market, 2021 - 2033 (USD Million)
Fig. 21 Leishmaniases market, 2021 - 2033 (USD Million)
Fig. 22 Soil-transmitted helminthiases market, 2021 - 2033 (USD Million)
Fig. 23 Others market, 2021 - 2033 (USD Million)
Fig. 24 Product market, 2021 - 2033 (USD Million)
Fig. 25 Drugs market, 2021 - 2033 (USD Million)
Fig. 26 Anti-Parasite market, 2021 - 2033 (USD Million)
Fig. 27 Antifungal market, 2021 - 2033 (USD Million)
Fig. 28 Antibiotics market, 2021 - 2033 (USD Million)
Fig. 29 Others market, 2021 - 2033 (USD Million)
Fig. 30 Vaccines market, 2021 - 2033 (USD Million)
Fig. 31 Neglected tropical disease treatment market revenue, by region
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 North America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 34 U.S. country dynamics
Fig. 35 U.S. neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 36 Canada country dynamics
Fig. 37 Canada neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 38 Mexico country dynamics
Fig. 39 Mexico neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 40 Europe neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 41 UK country dynamics
Fig. 42 UK neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 43 Germany country dynamics
Fig. 44 Germany neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 45 France country dynamics
Fig. 46 France neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 47 Italy country dynamics
Fig. 48 Italy neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 49 Spain country dynamics
Fig. 50 Spain neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 51 Norway country dynamics
Fig. 52 Norway neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 53 Sweden country dynamics
Fig. 54 Sweden neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 55 Denmark country dynamics
Fig. 56 Denmark neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 57 Asia Pacific neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 58 Japan country dynamics
Fig. 59 Japan neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 60 China country dynamics
Fig. 61 China neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 62 India country dynamics
Fig. 63 India neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 64 Australia country dynamics
Fig. 65 Australia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 66 South Korea country dynamics
Fig. 67 South Korea neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 68 Thailand country dynamics
Fig. 69 Thailand neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 70 Latin America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 71 Brazil country dynamics
Fig. 72 Brazil neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 73 Argentina country dynamics
Fig. 74 Argentina neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 75 MEA neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 76 South Africa country dynamics
Fig. 77 South Africa neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 78 Saudi Arabia country dynamics
Fig. 79 Saudi Arabia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 80 UAE country dynamics
Fig. 81 UAE neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 82 Kuwait country dynamics
Fig. 83 Kuwait neglected tropical disease treatment market, 2021 - 2033 (USD Million)
Fig. 84 Company categorization
Fig. 85 Company market position analysis
Fig. 86 Strategic framework